Osteoarthritis and Cartilage

Papers
(The H4-Index of Osteoarthritis and Cartilage is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review271
Macrophages regulate the progression of osteoarthritis236
Epidemiology of osteoarthritis195
Osteoarthritis year in review 2021: epidemiology & therapy160
The role of macrophages in osteoarthritis and cartilage repair140
Osteoarthritis year in review 2020: biology105
Trends in incidence and prevalence of osteoarthritis in the United Kingdom: findings from the Clinical Practice Research Datalink (CPRD)96
Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis95
The burden of OA-health services and economics85
Roles of NLRP3 inflammasome in intervertebral disc degeneration85
Osteoarthritis year in review 2020: epidemiology & therapy77
Identifying effector molecules, cells, and cytokines of innate immunity in OA63
Single-cell RNA-seq analysis identifies unique chondrocyte subsets and reveals involvement of ferroptosis in human intervertebral disc degeneration62
The innate immune response as a mediator of osteoarthritis pain61
Osteoarthritis year in review 2021: biology60
How does hip osteoarthritis differ from knee osteoarthritis?54
The causal role of gut microbiota in development of osteoarthritis53
Osteoarthritis-associated basic calcium phosphate crystals alter immune cell metabolism and promote M1 macrophage polarization52
The compartmental distribution of knee osteoarthritis – a systematic review and meta-analysis52
The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain51
Genetics of osteoarthritis49
Osteoarthritis year in review: genetics, genomics, epigenetics49
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis48
A lifespan approach to osteoarthritis prevention46
Osteoarthritis year in review 2020: rehabilitation and outcomes42
MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis41
tRNA-derived fragments (tRFs) regulate post-transcriptional gene expression via AGO-dependent mechanism in IL-1β stimulated chondrocytes41
Melatonin activates autophagy via the NF-κB signaling pathway to prevent extracellular matrix degeneration in intervertebral disc41
The effects of TNF-alpha inhibition on cartilage: a systematic review of preclinical studies41
Immediate outcomes following the GLA:D® program in Denmark, Canada and Australia. A longitudinal analysis including 28,370 patients with symptomatic knee or hip osteoarthritis40
The role of stromal cell-derived factor 1 on cartilage development and disease39
Fundamentals of OA. An initiative of Osteoarthritis and Cartilage. Obesity and metabolic factors in OA39
Sequencing identifies a distinct signature of circulating microRNAs in early radiographic knee osteoarthritis39
Factors secreted from dental pulp stem cells show multifaceted benefits for treating experimental temporomandibular joint osteoarthritis39
Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction38
Association between knee inflammation and knee pain in patients with knee osteoarthritis: a systematic review38
Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis37
Deep learning risk assessment models for predicting progression of radiographic medial joint space loss over a 48-MONTH follow-up period37
0.058429956436157